Triage mechanisms for directing protein refolding and degradation
Triage mechanisms for directing protein refolding and degradation
批准号:
9764391
负责人:
Richard C Page
金额:
$35.93万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2018
资助国家:
美国
项目状态:
已结题
起止时间:
2018-09-01 至 2023-08-31
关键词:
AreaAtaxiaBiochemicalBiological AssayBiophysicsCell physiologyCerebellar AtaxiaClientComplementComplexDataDefectDegradation PathwayDevelopmentDissectionElectron Spin Resonance SpectroscopyFutureHeat Shock 70kD Protein Binding ProteinHeat shock proteinsHumanHybridsInheritedKnowledgeLeadLocationMalignant NeoplasmsMediatingMethodsMolecular ChaperonesMolecular ConformationNeurodegenerative DisordersNuclear Magnetic ResonanceNucleotidesPathologyPathway interactionsPhysiologyPlayProteinsQuality ControlReperfusion InjuryResearchResolutionRoentgen RaysRoleSiteStructureSystemTechniquesTestingTriageUbiquitinationmisfolded proteinprogramsprotein misfoldingprotein protein interactionreal time monitoringresponsetherapeutic targetubiquitin mediated proteasome degradationubiquitin-protein ligase
中文摘要
项目总结
细胞蛋白质质量控制系统能够对蛋白质错误折叠做出强有力的反应,这对
细胞功能正常。多种病理疾病,包括神经退行性疾病、共济失调和癌症
可能是由E3泛素连接酶相互作用形成的蛋白质质量控制系统中的缺陷造成的
ChIP(Hsp70相互作用蛋白的C末端)和依赖于ATP的伴侣Hsp70(70kodalton热)
休克蛋白)。尽管CHIP/Hsp70蛋白质质量控制复合体很重要,但分类
CHIP/Hsp70复合体用于靶向错误折叠的蛋白质进行Hsp70介导的重折叠的机制
或者泛素蛋白酶体介导的降解是未知的。在分类机制内,有几个关键领域
仍未被开发。这些包括:(1)芯片/Hsp70复合体如何执行观察到的分诊
首先泛化错误折叠的客户端,然后是Hsp70,然后是芯片的机制?(2)
Hsp70的核苷酸占有率和整个催化过程中Hsp70的构象变化
周期决定芯片使错误折叠的客户端无处不在的能力?(3)控制的决定因素是什么
错误折叠的客户是变得无处不在,还是重新折叠?拟议的研究计划将审查
这些问题使用核磁共振(核磁共振)、小角X射线散射(SAXS)、电子
顺磁共振(EPR),以及一套生物物理和生化技术。核磁共振数据将提供
关于芯片/Hsp70/客户复合体内部动力学的高分辨率信息,并支持详细剖析
动力学在决定CHIP/HSP70分流机制中所起的作用。将使用SAXS和EPR
在混合方法中一起确定动态CHIP/HSP70复合体的结构系综
并将动态构象变化与芯片介导的Hsp70泛素化和
弄错了客户。SAXS/EPR混合方法在结构分析中的应用
确定将产生一种适用于许多蛋白质/蛋白质相互作用的方法
动态构象变化。来自核磁共振、SAXS和EPR的结构数据将得到补充
生物物理和生化方法,能够实时监测泛素化和直接化验
芯片介导的泛素化和Hsp70介导的蛋白质复性之间的竞争。这些化验
将允许快速测试从核磁共振和SAXS/EPR结构生成的机械假设
学习。建议的研究计划旨在通过扩展以检查客户所扮演的角色来进行发展
在分类机制中。这些努力将扩展到可溶性蛋白质客户,无论是受到干扰的折叠
泛素化能力,或泛素化位点的受控数量或位置。
英文摘要
PROJECT SUMMARY
Cellular protein quality control systems enable the robust response to protein misfolding that is essential for
normal cellular function. Numerous pathologies including neurodegenerative disorders, ataxias, and cancers
can result from defects in the protein quality control system formed by the interaction of the E3 ubiquitin ligase
CHIP (C-terminus of Hsp70 Interacting Protein) and the ATP-dependent chaperone Hsp70 (70 kilodalton heat
shock protein). Despite the importance of the CHIP/Hsp70 protein quality control complex, the triage
mechanism used by the CHIP/Hsp70 complex to target misfolded proteins for either Hsp70-mediated refolding
or ubiquitin proteasome-mediated degradation is unknown. Within the triage mechanism, several key areas
remain unexplored. These include: (1) How does the CHIP/Hsp70 complex execute the observed triage
mechanism that ubiquitinates misfolded clients first, then Hsp70, then CHIP? (2) What is the role played by
nucleotide occupancy of Hsp70 and how do the conformational changes in Hsp70 throughout the catalytic
cycle dictate the ability of CHIP to ubiquitinate misfolded clients? (3) What are the determinants that control
whether a misfolded client becomes ubiquitinated, or is refolded? The proposed research program will examine
these issues using nuclear magnetic resonance (NMR), small angle X-ray scattering (SAXS), electron
paramagnetic resonance (EPR), and a suite of biophysical and biochemical techniques. NMR data will provide
high-resolution information on dynamics within CHIP/Hsp70/client complexes and enable a detailed dissection
of the role that dynamics play in dictating the CHIP/Hsp70 triage mechanism. SAXS and EPR will be used
together in a hybrid methods approach to determine structural ensembles for dynamic CHIP/Hsp70 complexes
and connect dynamic conformational changes to alterations in CHIP-mediated ubiquitination of Hsp70 and
misfolded clients. The proposed development of a SAXS/EPR hybrid methods approach to structure
determination will produce an approach that will be applicable to many protein/protein interactions regulated by
dynamic conformational changes. Structural data from NMR, SAXS, and EPR will be complemented with
biophysical and biochemical approaches that enable real-time monitoring of ubiquitination and directly assay
the competition between CHIP-mediated ubiquitination and Hsp70-mediated protein refolding. These assays
will allow for rapid testing of mechanistic hypotheses generated from the NMR and SAXS/EPR structural
studies. The proposed research program is set up to evolve by expanding to examine the role that clients play
in the triage mechanism. These efforts will be extended to soluble protein clients with either perturbed refolding
capabilities, or controlled numbers or locations of ubiquitination sites.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Triage mechanisms for directing protein refolding and degradation
-
批准号:10462587
-
项目类别:
-
资助金额:$35.93万
-
财政年份:2018
-
负责人:Richard C Page
-
依托单位:
海外基金